Expressions of inhibitory checkpoint molecules in acute and chronic HBV and HCV infections: Implications for therapeutic monitoring and personalized therapyReview Published on 2020-03-012023-06-12 Journal: Reviews in Medical Virology [Category] B형 간염, [키워드] Hepatitis Inhibitory Receptors PD-1 T-cell exhaustion therapy [DOI] 10.1002/rmv.2094 [Article Type] Review
Diverse Role of TGF-β in Kidney DiseaseReview Published on 2020-02-282024-09-02 Journal: Frontiers in Cell and Developmental Biology [Category] 대상포진, [키워드] fibrosis Inflammation mechanisms Smads TGF-β therapy [DOI] 10.3389/fcell.2020.00123 PMC 바로가기 [Article Type] Review
Current Antivirals and Novel Botanical Molecules Interfering With Herpes Simplex Virus InfectionReview Published on 2020-02-112024-09-02 Journal: Frontiers in Microbiology [Category] 대상포진, [키워드] antiviral extracts HSV-1 HSV-2 natural antiviral compounds phytopharmaceuticals therapy [DOI] 10.3389/fmicb.2020.00139 PMC 바로가기 [Article Type] Review
Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, ChinaOpinion Article Published on 2020-02-072022-10-31 Journal: F1000Research [Category] COVID-19, MERS, SARS, [키워드] 2019-nCoV 2019-nCoV infection ACE2 ACE2-Fc acute respiratory distress angiotensin-converting enzyme 2 approaches biologic block breath build clinical trial compassionate use coronavirus current death develop domain effective therapy effort fused help helping immune system Immunity Immunoglobulin infected individuals infected patient Infection investigators lung mechanism of action monoclonal antibody Mutation Neutralizing neutralizing antibody Novel coronavirus outbreak pandemic pathophysiology Patient patients Prevent producing Protective Protein protein expression provided quarantine receptor recruit Research respiratory viral sequence therapy treat Treatment Vaccine viral escape viral RNA genome virus while Wuhan Wuhan, China [DOI] 10.12688/f1000research.22211.2 PMC 바로가기 [Article Type] Opinion Article
Approaches for the Treatment of SARS-CoV-2 Infection: A Pharmacologic View and Literature ReviewReview Article Published on 2020-01-012022-10-30 Journal: Iranian Journal of Pharmaceutical Research : IJPR [Category] COVID-19, [키워드] acute respiratory distress acute respiratory distress syndrome (ARDS) approach ARDS caused China clinical manifestations clinical trial coronavirus coronavirus 2 Coronavirus disease 2019 COVID-19 COVID-19 disease disease drugs targeting effective effective drug effort elements host cell identify knowledge literature medication Mild moderate new virus offered outcomes pandemic Pharmacologic potential therapy public health Quickly respiratory review SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 virus severity Spread Stage suggested syndrome the disease therapy Treatment View virus [DOI] 10.22037/ijpr.2020.113821.14506 PMC 바로가기 [Article Type] Review Article
SARS-CoV-2/COVID-19, Lymphatic vessels, lymph, and lymphologyEditorial Published on 2020-01-012023-07-05 Journal: Lymphology [Category] SARS, [키워드] COVID-19 lymph lymphatic vessels pathophysiology SARS-CoV-2 therapy [Article Type] Editorial
Clinical characteristics and plasma antibody titer of patients with COVID-19 in Zhejiang, China중국 저장성 COVID-19 환자의 임상적 특성 및 혈장 항체가Article Published on 2020-01-012022-09-12 Journal: Journal of Zhejiang University. Science. B [Category] MERS, 진단, [키워드] acute respiratory syndrome affected age anti-viral drug antibody Antibody titer Berry caused Characteristics China clinical Clinical characteristics common cold Convalescent patients convalescent plasma coronavirus Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 critically ill patients Donor effective Fatality rate female gastroenteritis Human humans IgG IgM immunization Immunoglobulin G improve clinical outcome increase Infection Infectious disease male Mild Neutralizing Neutralizing antibody titer offer patients with COVID-19 pilot study plasma antibody Pneumonia progression report reported SARS-CoV-2 severe COVID-19 severely ill patient shown the disease therapeutic efficacy therapeutic strategy therapy treating COVID-19 upper respiratory tract Vaccine Viremia WHO World Health Organization Zhejiang [DOI] 10.1631/jzus.B2000593 PMC 바로가기 [Article Type] Article
Targeting Natural Products for the Treatment of COVID-19 – An Updated ReviewReview Published on 2020-01-012023-07-05 Journal: Current pharmaceutical design [Category] SARS, [키워드] anti-viral property COVID-19 natural products Pathogenesis SARS-CoV2 therapy [DOI] 10.2174/1381612826666200903122536 [Article Type] Review
[Features of pathogenesis and COVID-19 course for the elderly and old age]Article Published on 2020-01-012023-07-05 Journal: Advances in gerontology = Uspekhi gerontologii [Category] SARS, [키워드] Coronavirus infection elderly patients Hemostasis immune response therapy
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipelineAnti-SARS-CoV-2 중화 단일클론항체: 임상 파이프라인Article Published on 2020-01-012022-09-11 Journal: mAbs [Category] MERS, SARS, 유전자 메커니즘, 임상, 진단, [키워드] anti-SARS-CoV-2 antibody bamlanivimab BGB-DXP593 candidate clinical trials Convalescent plasma therapy COVID-19 COVID-19 pandemic CT-P59 disease Ebolavirus Efficacy focus GSK4182136 LY-CoV016 LY-CoV555 mAb mAb cocktails mAbs mechanism mechanism of action monoclonal monoclonal antibody Neutralizing ongoing trial ongoing trials phase Phase 2 Pneumonia REGN-CoV2 Research research and development respiratory syncytial virus SARS-CoV-2 therapy VIR-7831 Viral viral infections virus pneumonia while [DOI] 10.1080/19420862.2020.1854149 PMC 바로가기 [Article Type] Article